Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Daunorubicin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 37,591Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jazz Pharmaceuticals to Showcase Rapidly Expanding Oncology Pipeline
    Jazz Pharmaceuticals to Showcase Rapidly Expanding Oncology Pipeline

    27 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-showcase-rapidly-expanding-oncology-pipeline-and-advances-in-current-product-portfolio-at-asco-2023-301809003.html

    PR NEWSWIRE
    27 Apr 2023
    Share Share
    Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML
    Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML

    20 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230420005738/en

    BUSINESSWIRE
    20 Apr 2023
    Share Share
    Jazz Pharma Secures Eight Additional Provincial Reimbursements for Vyxeos
    Jazz Pharma Secures Eight Additional Provincial Reimbursements for Vyxeos

    08 Mar 2023

    // PRESS RELEASE

    https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-secures-eight-additional-provincial

    PRESS RELEASE
    08 Mar 2023
    Share Share
    Teva's troubled plant seen to create injectable drug shortages
    Teva's troubled plant seen to create injectable drug shortages

    24 May 2022

    // Joseph Keenan FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/tevas-halt-production-troubled-plant-seen-create-shortages-range-injectables

    Joseph Keenan FIERCEPHARMA
    24 May 2022
    Share Share
    BDR launches India’s first generic Midostaurin (MSTARIN) to treat Leukemia
    BDR launches India’s first generic Midostaurin (MSTARIN) to treat Leukemia

    07 Dec 2021

    // EXPRESS PHARMA

    https://www.expresspharma.in/bdr-pharmaceuticals-launches-indias-first-generic-midostaurin-mstarin-to-treat-leukemia/

    EXPRESS PHARMA
    07 Dec 2021
    Share Share
    Jazz Announces FDA Approval of Additional Indication for Vyxeos®
    Jazz Announces FDA Approval of Additional Indication for Vyxeos®

    30 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-fda-approval-of-additional-indication-for-vyxeos-daunorubicin-and-cytarabine-for-the-treatment-of-secondary-acute-myeloid-leukemia-in-pediatric-patients-301259059.html

    PRNEWSWIRE
    30 Mar 2021
    Share Share